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  emophilia is a common hereditary hemorrhagic disorder, however little is known about the oral microflora of hemophilic
patients. The aim of this study was to quantify the Candida and identify its species in non-stimulated saliva of hemophilic
patients, and consider its relationship with clinical factors influencing Candida carriage. This study comprised evaluation of
86 hemophilic patients of the Hematology Center/UNICAMP and 43 healthy subjects as controls. All patients were submitted
to anamnesis, intraoral examination and unstimulated saliva collection. Candida counts and species identification were performed
in salivary samples. Candida was present in 64% of the hemophilic patients and in 44% of the healthy controls. C. albicans
represented 65% and 68% of the isolated species, in hemophiliacs and control group respectively, and C. tropicalis was the
second most common species in both groups. These results indicate that hemophilic patients carry Candida more frequently
and in higher counts than healthy controls, independently of oral clinical parameter considered, as viral infections, complete
dentures, transfusions of hemoderivatives, and salivary flow.
Uniterms: Candida; Hemophiliacs; Candidosis; Hemophilia; Candida tropicalis.
  emofilia é uma alteração hemorrágica hereditária comum, entretanto pouco se sabe a respeito da microbiota oral destes
indivíduos. O objetivo deste estudo foi quantificar a presença de Candida e identificar as suas espécies na saliva de hemofílicos,
correlacionando os resultados com fatores clínicos que possam influenciar a presença deste fungo. Foram avaliados 86
hemofílicos do Hemocentro/UNICAMP e 43 indivíduos saudáveis. Todos os pacientes foram submetidos a anamnese, exame
clínico intra-oral e coleta de saliva de forma não estimulada. A quantificação e identificação das espécies de Candida foram
realizadas nas amostras de saliva. Candida estava presente em 64% dos hemofílicos e em 44% dos indivíduos saudáveis. C.
albicans representou 65% e 68% das espécies identificadas, nos hemofílicos e grupo controle respectivamente, e C. tropicalis
foi a segunda espécie mais comum. Estes resultados sugerem que pacientes hemofílicos albergam mais freqüentemente
Candida na cavidade bucal e em maiores quantidades que os indivíduos do grupo controle, independentemente dos parâmetros
clínicos analisados, como infecção viral, próteses dentárias, transfusões de hemoderivados e fluxo salivar.
Unitermos: Candida; Hemofílicos; Candidose; Hemofilia.
INTRODUCTION
Hemophilia is a hemorrhagic disorder caused by
hereditary deficiency of factor VIII or IX, characterizing
hemophilia A and B, respectively2,5,14. Hemophilia A is caused
by reduction of the serum level or activity of factor VIII, an
important protein in the activation of factor X in the blood
clotting sequence. The disease shows an X-linked recessive
pattern, affecting predominantly males. According to factor
VIII activity detected in blood, hemophilia is classified in
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mild (6 to 30% of activity), moderate (2 to 5%) and severe
(less than 1%). Hemorrhagic episodes are related to the
severity of the disease, although all patients can suffer
hemorrhage following trauma or surgical procedures2,5,13.
Hemophilia B is characterized by deficiency of factor IX
with its pattern of transmission and clinical characteristics
similar to hemophilia A13.
Candida species have been found in the oral cavity of
25 to 50% of healthy subjects1,12. C. albicans is the most
common, representing 60 to 90% of the isolated species9,29.
Local and systemic factors can modify Candida carriage in
the mouth as patients’ age and gender, complete dentures,
smoking, xerostomia, diabetes, drugs and genetic or acquired
immunological deficiency12,19.
Many studies have focused dental management in
hemophilic patients, however few papers have dealt with
oral microflora17,25. Candida carriage in these patients could
be modified by administration of hemoderivatives or other
drugs, and alterations in the immunological system as a
consequence of infections, as HBV, HCV and/or HIV4,24. The
aim of this paper was to quantify Candida in saliva and
identify its species in normal and hemophilic patients,
considering clinical factors that could influence Candida
carriage in the oral cavity.
MATERIAL AND METHODS
A total of 129 patients were studied, 86 with hemophilia
from the Hematology and Hemotherapy Center/UNICAMP,
and 43 healthy subjects as control. All hemophiliacs were
males, with a mean age of 27.5 years (range from 3 to 69
years). They were classified according to hemophilia type
(A or B) and severity of the disease. Previous hemorrhagic
episodes, blood or hemoderivatives transfusions,
serological data, and occurrence of viral infections were
considered. Control patients did not have any history of
previous or present systemic disease. The male to female
ratio was 1.0:0.8 (24/19), with a mean age 29.3 years old
(range from 7 to 60 years).
All patients were submitted to physical intraoral
examination and collection of unstimulated saliva for 5 min.
Salivary flow was classified as reduced (< 0.2mL/min), normal
(> 0.3 and < 0.4mL/min) and abundant (> 0.5mL/min),
according to the criteria described by Screebny, et al.23
(1989). Salivary samples were cultured in Saboraud dextrose
agar with chloramphenicol for 48 hours, and Candida counts
were expressed as CFU/ml. According to Candida count,
each patient was considered “negative” (CFU/mL = 0),
“carrier” (CFU/mL > 0 or < 400) and “positive” (CFU/mL <
400). Candida species identification was performed by germ
tube and chlamydospores production, and carbohydrate
fermentation and assimilation, according to Sandvén22 (1990)
and Larone10 (1995).
Data were statistically analyzed by t test, chi-square,
Wilcoxon, Kruskal-Wallis and two-tailed exact Fischer, using
the EPI-INFO 6.04b program (CDC, USA), at a significance
level of 5%.
RESULTS
Twenty-nine (34%) out of 86 hemophiliacs showed one
or more viral infections diagnosed by serological tests (Table
1). Most of the patients with severe hemophilia A presented
viral infections, and HCV was the most common, followed
by HIV and CMV. Only one patient had HBV, and 8 presented
simultaneous infections with two or more virus. Surprisingly
no patient with severe Hemophilia B was infected, but 4 out
of 8 with mild Hemophilia B were positive for HCV and one
for HIV. Twenty-one patients had one viral infection and
eight, two or more (HCV + HIV = 1, HCV + CMV = 2, HCV +
HIV + HBV = 1, and HCV + HIV + CMV = 4). Smoking and
drinking habits were higher in the control group, but use of
drugs and prosthesis was similar in both groups (Table 2).
Mean salivary flow rates of both groups were statistically
different (p = 0.0025), but within the range of normal values,
0.49±0.11mL/min and 0.41±0.21mL/min for the control and
hemophilic groups, respectively. Nevertheless, in both
groups, few patients had reduced salivary flow. Candida
Hemophilia Viral Infection
HCV HIV HBV CMV Two or more
viruses
Hemophilia A(68)
Severe (n = 34) 16 (61.5%) 6 (75.0%) 0 6 (86.0%) 7 (87.5%)
Moderate (n = 18) 3 (11.5%) 0 0 1 (14.0%) 0
Mild (n = 16) 2 (8.0%) 1 (12.5%) 1 (100%) 0 1 (12.5%)
Hemophilia B(18)
Severe (n = 5) 0 0 0 0 0
Moderate (n = 5) 1 (4.0%) 0 0 0 0
Mild (n = 8) 4 (15.0%) 1 (12.5%) 0 0 0
Total (n = 86) 26 (30.23%) 8 (9.3%) 1 (1.16%) 7 (8.13%) 8 (9.3%)
TABLE 1- Distribution of 86 hemophilic patients regarding to type of hemophilia, severity of the disease and viral infections
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was not detected in saliva of 56% of control patients, and
36% of the hemophiliacs. On the other hand, 42% of the
hemophiliacs were considered positive, but only 28% of the
controls. Type and severity of hemophilia did not influence
the presence of Candida in saliva (Table 3).
About 73% of the HCV-positive patients and 87.5% of
the HIV-positive patients were Candida carriers/positive in
saliva. To assess the influence of these viral infections on
Candida carriage in saliva, patients affected by each of the
infections (HIV, HCV, HBV, and CMV) were excluded and
Candida carriage was analyzed in the remaining individuals.
Results showed no statistically significant differences
between groups and in the hemophilic group as a whole. On
the other hand, when considering only hemophiliacs with
viral infections, they carried more Candida in saliva when
compared to control and hemophilic group without viral
infections (Table 4). The influence from complete dentures
and salivary flow on salivary Candida carriage in hemophilic
patients was also analyzed, and exclusion of one or both of
these factors did not interfere with Candida counts (Table
5).
Regarding Candida species, C. albicans corresponded
to 68 and 65%, C. tropicalis 37 and 51%, and Candida sp 26
and 9% in the control and hemophilic groups, respectively.
C. krusei (1 patient) and Rhodotorula rubra (1 patient) were
also isolated from hemophiliacs (Table 6).
DISCUSSION
Hemophilia is a hereditary hemorrhagic disorder,
characterized by deficiency in factors VIII or IX, which are
fundamental glycoproteins in blood clotting2,26. Some
primary or secondary hemophilia-related factors, as viral
infections and transfusion therapies, can interfere with the
immune system and predispose hemophiliacs to alterations
in oral microflora and, consequently, to oral infections6,8,21.
The present results showed that Candida was more
frequently found in the saliva of hemophilic patients (64%)
than in controls (44%). It was also noticed that, although
the frequency of Candida carriers/positives was higher in
hemophiliacs, there were no cases of clinical oral candidiasis.
Parameter Control (43) Hemophiliacs (86) p value
n (%) n (%)
Smoking 7 (16.3%) 3 (3.6%) p= 0.015
Drinking 4 (10.3%) 0 (0.0%) p= 0.011
Prosthesis 1 (2.4%) 7 (8.9%) NS
Drugs 2 (4.9%) 2 (2.4%) NS
TABLE 2- Distribution of 86 patients and 43 healthy individuals regarding to smoking and drinking habits, complete dentures,
and drug use
Type of hemophilia Salivary Candida carriage Mean CFU
Positive Carrier Negative
(CFU1 /mL <400) (CFU/mL>0<400) (CFU/mL= 0)
Hemophilia A (68)
Severe (n=34) 16 (47%) 7 (20.5%) 11 (32.5%) 3.899 ± 2.615
Moderate (n=18) 8 (44%) 4 (22%) 6 (33%) 3.255 ± 1.806
Mild (n=16) 5 (31%) 5 (31%) 6 (38%) 2.717 ± 0.832
Hemophilia B (18)
Severe (n=5) 2 (40%) 2 (40%) 1 (20%) 3.723 ± 2.760
Moderate (n=5) 2 (40%) 1 (20%) 2 (40%) 5.403 ± 3.719
Mild (n=8) 0 3 (37%) 5 (63%) 4.633 ± 2.481
Total (n = 86) 33 (38.4%) 22 (25.6%) 31 (36%) 3.653 ± 2.275
Control (n = 43) 12 (28%) 7 (16%) 24 (56%) 2.558 ± 0.910
TABLE 3- Distribution of control and hemophilic patients regarding to salivary Candida carriage
1 CFU – colony forming units in log10/mL
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Patients affected by severe hemophilia A or B need more
frequent transfusional therapies and could be more
susceptible to infections8,13. However, in the present patients,
severity of hemophilia did not correlate with Candida counts
in saliva, indicating that transfusions did not significantly
impair immune defense to Candida.
Reduced salivary flow has been considered the most
important factor leading to Candida carriage and
development of candidosis7,15,19. In the present study, the
mean salivary flow rates of both groups, although different,
were within normal range. Therefore the increased salivary
Candida carriage in hemophiliacs cannot be explained
simply considering salivary flow.
Several systemic factors have been related to oral
candidiasis, such as immunosuppression, HIV and other
viral infections3,4,16,27. From 86 hemophilic patients, 8 were
HIV-positive, and of these, 7 were Candida carriers/positives
in saliva. All 8 patients were using anti-retroviral therapies
without clinical disease. It is well known that HIV is an
important factor for Candida colonization of the oral
cavity18,28. HCV and CMV infections did not influence
salivary Candida carriage. In the present sample, only one
HBV patient was positive to salivary Candida. When only
individuals with viral infections were analyzed, about 73%
of hemophiliacs were Candida carriers/positive in saliva.
This clearly indicates that other infections are positively
related to the presence of Candida in the mouth.
Nevertheless, the relatively small number of patients studied
Group Positive Carrier Negative
(CFU/mL <400) (CFU/mL >0<400) (CFU/mL = 0)
Hemophiliacs with viral infections (n = 29) 15 (51.7%) 6 (20.6%) 8 (27.5%)
Hemophiliacs without viral infections (n = 57) 21 (37%) 13 (23%) 23 (40%)
Total (n = 86) 33 (38.4%) 22 (25.6%) 31 (36%)
Control (n = 43) 12 (28%) 7 (16%) 24 (56%)
TABLE 4- Influence of viral infection in salivary Candida carriage in hemophiliacs with and without viral infections and control
group
Parameters Salivary Candida carriage
Positive Carrier Negative
(CFU/mL <400) (CFU/mL >0<400) (CFU/mL = 0)
All hemophiliacs (n = 86) 33 (38.4%) 22 (25.6%) 31 (36%)
Excluding oral prosthesis (n = 79) 31 (39%) 18 (23%) 30 (38%)
Excluding reduced salivary flow (n = 72) 28 (39%) 18 (25%) 26 (36%)
Excluding both factors above (n = 52) 20 (39%) 10 (19%) 22 (42%)
Excluding both factors above and viral infections (n = 40) 14 (35%) 7 (17.5%) 19 (47.5%)
TABLE 5- Influence of oral prosthesis (complete dentures) and reduced salivary flow in salivary Candida carriage in
hemophilic patients
Candida species Control (n = 43) Hemophiliacs (n = 86)
n (%) n (%)
C. albicans 13 (68%) 36 (65%)
C. tropicalis 7 (37%) 28 (51%)
Candida sp 5 (26%) 5 (9%)
C. krusei 0 1 (2%)
Rhodotorula rubra 0 1 (2%)
TABLE 6- Candida species found in control and hemophilic patients
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should be considered, and in some cases the viral disease
was under control, as in HIV patients.
C. albicans is the most common oral Candida species,
representing 60 to 90% of the isolates in normal and
immunocompromised individuals8,20. The present results
revealed that C. albicans and C. tropicalis were the most
common species in controls and hemophiliacs. When
considered the 40 hemophilic patients without any local or
systemic factors (viral infections, complete dentures, and
salivary flow), 21 were Candida carriers/positives in saliva
and, from these, 16 (76%) were positive for C. albicans and
10 (47%) for C. tropicalis, showing that former group carried
more Candida than the control.
It is interesting to note the high frequency of C. tropicalis
in patients of both groups, not reflecting the literature
data1,11. This can be interpreted as a regional higher incidence
of C. tropicalis in the present population and should be
better clarified.
CONCLUSION
In summary, in the present study, hemophiliacs showed
higher salivary Candida counts and higher number of
individuals carriers/positives for Candida when compared
to controls. Viral infections facilitated the presence of
Candida in the mouth, nevertheless hemophiliacs without
any viral infections significantly carried more Candida than
controls. No factor could be found, inherent or not to
hemophilia, that could significantly contribute to the
increased salivary Candida counts in these patients, and
this deserves further studies.
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